Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-3576
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-3576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Valsartan Hctz Figure 1)
Figure-2 (Valsartan Hctz Figure 2)
This appears to be a table showing blood pressure readings and medication dosages. The first line indicates that the diastolic blood pressure (DBP) is less than 90 mmHg. The next line shows the medication being taken, including Valsartan and Hydrochlorothiazide in specific dosages. The numbers in the following lines indicate the blood pressure readings before and after treatment, with a baseline reading of 105 mmHg.*
Figure-3 (Valsartan Hctz Figure 3)
Figure-4 (Valsartan Hctz Figure 4)
This is a table that displays the baseline diastolic blood pressure (DBP) values in mmHg of participants in a clinical trial. The participants were assigned to different treatment groups and doses of medication, including Valsartan HCT 320/125mg, Valsartan 320mg, Hydrochlorothiazide 25mg, and placebo. The DBP values range from 95 to 105 mmHg.*
Hctz-stru (Valsartan Hctz Hydrochlorothiazide)
Valsartan-str (Valsartan Hctz Valsartan)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.